Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer

  • Conforti, Fabio M.D.
  • Oriecuia, Chiara Ph.D.
  • Pala, Laura M.D.

  • 1University of Milan, Milan

    2University of Brescia, Brescia, Italy

    3Humanitas Gavazzeni, Bergamo, Italy

Dr. Conforti can be contacted at [email protected].

No potential conflict of interest relevant to this letter was reported.

New England Journal of Medicine 392(8):p 830, February 20, 2025.
Copyright © 2025 Massachusetts Medical Society. All rights reserved.